Aeterna Zentaris Inc. had a pretty favorable run when it comes to the market performance. AEterna Zentaris's Stock Price And Volume Action AEterna Zentaris's (NASDAQ:AEZS) stock is trading up 16.54% to a price of $1.09. Shares of Aeterna Zentaris (NASDAQ: AEZS) stock are 40% higher on some pretty interesting news. The company's pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. AEterna Zentaris Inc. (AEZS) stock is trading at $1.36 as of 10:35 AM on Monday, Feb 8, a rise of $0.25, or 22.42% from the previous closing price of $1.11. Get the latest stock price for AEterna Zentaris Inc. (AEZS), plus the latest news, recent trades, charting, insider activity, and analyst ratings. On November 17, 2015, the company effected a 100-to-1 Share Consolidation (reverse stock split). Aeterna Zentaris overview. The company belongs in the Biotechnology industry, Healthcare sector and employs 11 … View AEZS's stock ratings, price targets, earnings, commentary and news at Smarter Analyst. The stock of AEterna Zentaris (NAS:AEZS, 30-year Financials) is believed to be significantly overvalued, according to GuruFocus Value calculation.GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded. AEZS- Upcoming Six Catalysts ( Q2,2021) for below Pharma Drugs : COVID-19 Pill. Research AEterna Zentaris Inc. (USA) stock. stock was originally listed at a price of $6,378.00 in May 10, 2000. The 1-year high price for the company’s stock is recorded $3.6200 on 02/08/21, with the lowest value was $0.4200 for the same time period, recorded on 01/04/21. using the scroll bar or pinch and zoom on a touch screen). AGHD - Adult Growth Hormone Deficiency. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. This was a 1 for 6 reverse split, meaning for each 6 shares of AEZS owned pre-split, the shareholder now owned 1 share. About Aeterna Zentaris Inc. Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Aeterna Zentaris Inc. has a license agreement with Julius-Maximilians-University Wuerzburg for the development of an oral prophylactic bacterial vaccine against COVID-19 disease; development, manufacture, and commercialization of targeted immunosuppressive therapeutic proteins for the treatment of neuromyelitis optica spectrum disorder. Aeterna Zentaris Inc.’s Net Margin is presently recorded at -140.14. The vaccine is currently in preclinical development and was invented at the Julius-Maximilians-University in Wuerzburg. Aeterna Zentaris commences late-stage growth hormone deficiency trial Seeking Alpha - 5/13/2021 8:26:05 AM: Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/13/2021 8:15:46 AM Aeterna Zentaris Commences Pivotal Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency GlobeNewswire Inc. - 5/13/2021 8:05:00 AM Find the latest Aeterna Zentaris Inc. (AEZS) stock discussion in Yahoo Finance's forum. Upon looking at major shareholders, it appears that insiders hold 0.09% of Aeterna Zentaris Inc. shares, and 3.12% of them are in the hands of institutional investors. Aeterna Zentaris Inc. (NASDAQ:AEZS) went up by 21.89% from its latest closing price compared to the recent 1-year high of $3.62. Press Release reported on 03/25/21 that Aeterna Zentaris Reports Fourth Quarter and Full Year 2020 Financial Results. View the real-time AEZS price chart on Robinhood and decide if you want to buy or sell commission-free. AEZS stock quote, chart and news. Aeterna Zentaris Inc. (AEZS) full year performance was 135.63% Post-Market 0.01 (0.66%) What Makes Aeterna Zentaris (AEZS) a New Buy Stock 10/08/19-8:00AM EST Zacks Aeterna Zentaris (AEZS) Beats Q2 Earnings Estimates 08/13/19-4:45PM EST Zacks AEZS updated stock price target summary. AEterna Zentaris's stock resumes trade, plunges 48% premarket after Phase 3 trial disappoints May. AEterna Zentaris Inc. (AEZS) stock is trading at $1.36 as of 10:35 AM on Monday, Feb 8, a rise of $0.25, or 22.42% from the previous closing price of $1.11. AEZS: Get the latest AEterna Zentaris stock price and detailed information including AEZS news, historical charts and realtime prices. It is calculated based on the historical multiples that the stock has traded at, the past business growth and analyst estimates of future … During the last session, Aeterna Zentaris Inc. (NASDAQ:AEZS)’s traded shares were 1,255,459, with the beta value of the company hitting 1.94. The relative strength of a dividend stock indicates whether the stock is uptrending or not. Aeterna Zentaris Inc. stock and Biotechnology market discussion, news, and analysis from Canada's largest community of active investors. Aeterna Zentaris Inc. Common Stock (AEZS) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Before that, on July 19, 2017, Maxim Group Recapitulated a Buy rating and elevated its amount target to $4. Its lead endocrinology program is a Phase 3 trial in benign prostatic hyperplasia (BPH) with cetrorelix, an LHRH antagonist already marketed for in vitro fertilization under the brand name Cetrotide. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Aeterna Zentaris against related stocks people … Why the climb? View AEterna Zentaris Inc. AEZS investment & stock information. AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. Aeterna Zentaris Inc. (AEZS) full year performance was 16.96% This wholly-owned subsidiary, which is based in the Charleston, South Carolina area, conducts certain of its administrative and commercial operations. Find real-time AEZS - Aeterna Zentaris Inc stock quotes, company profile, news and forecasts from CNN Business. Aeterna Zentaris Inc. (NASDAQ:AEZS) has risen 15.47% to $1.08 in premarket trading hours on the last check Monday. At the end of the trading day, the stock’s price was $0.87, reflecting an intraday loss of -2.95% or -$0.02. The current price of Aeterna Zentaris is the price at which Aeterna Zentaris is currently trading. Its lead product is macimorelin, a peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone … Aeterna Zentaris Inc. (NASDAQ:AEZS) went down by -3.40% from its latest closing price compared to the recent 1-year high of $3.62. CHARLESTON, S.C., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that it has received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has been granted an … 1, 2017 at 8:32 a.m. Volume today is 13,379,341 compared to average volume of 16,438,191. Pessimistic forecast: 0.87 Optimistic: 0.89 Aeterna Zentaris stock forecast for 22.05.2021. Aeterna Zentaris stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2021. Get instant access to a free live streaming chart of the Aeterna Zentaris Inc Stock. CGHD - Child Growth Hormone Deficiency The AEterna Zentaris Inc. stock price gained 1.94% on the last trading day (Friday, 21st May 2021), rising from $0.88 to $0.90. Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Aeterna Zentaris (AEZS) stock price, charts, trades & the US's most popular discussion forums. AEterna Zentaris Inc. (USA) NASDAQ Updated May 21, 2021 11:56 PM AEZS 0.90 0.02 (1.95%). Get the latest AEterna Zentaris Inc. (AEZS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. AEterna Zentaris's (NASDAQ:AEZS) stock is trading up 13.13% to a price of $1.32.The stock's current volume for the day is … AETERNA ZENTARIS ANNOUNCES CLOSING OF $12 MILLION PUBLIC OFFERING. Aeterna Zentaris Inc (NASDAQ: AEZS) has exercised its option announced on February 2, and entered into an exclusive worldwide sub-licensable patent and know-how license agreement for a potential COVID-19 vaccine. The all-time high AEterna Zentaris stock closing price was 6826.63 on June 16, 2000.; The AEterna Zentaris 52-week high stock price is 3.62, which is 316.1% above the current share price. The stock of AEterna Zentaris (NAS:AEZS, 30-year Financials) is believed to be significantly overvalued, according to GuruFocus Value calculation.GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded. The latest closing stock price for AEterna Zentaris as of May 24, 2021 is 0.87.. Historical daily share price chart and data for AEterna Zentaris since 2021 adjusted for splits. Aeterna Zentaris (AEZS) stock is soaring higher on Monday with heavy trading even with there being a lack of news about the company. Cookies are used to offer you a better browsing experience and to analyze our traffic. It is usually referred to as TSX:AEZS or AEZS-T Is AEterna Zentaris Inc. a buy or a sell? View real-time stock prices and stock quotes for a full financial overview. The technique we employ is simple. That means it could easily issue a few shares to fund more growth, and might well be in a position to borrow cheaply. The stock of AEterna Zentaris (NAS:AEZS, 30-year Financials) is believed to be significantly overvalued, according to GuruFocus Value calculation.GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded. Aeterna Zentaris Inc. () Stock Market info Recommendations: Buy or sell Aeterna Zentaris stock? Current stock quote for Aeterna Zentaris Inc. ( T.AEZS ) including financial statements, level 2 data, and the latest Biotechnology news, research, and investment community discussion Post-Market 0.01 (0.73%) Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Today, biotech penny stocks are once again in the investor spotlight. Aeterna Zentaris Inc. [NASDAQ: AEZS] stock went on a downward path that fall over -14.39% on Monday, amounting to a one-week price decrease of less than -15.16%. At the close of Friday’s trading session, Aeterna stock had increased by 0.43% to reach $0.94. About the Æterna Zentaris, Inc. stock forecast. The vaccine is currently in preclinical development and was invented at the Julius-Maximilians-University in Wuerzburg. Aeterna Zentaris Inc. (AEZS) saw downtrend of -3.48% in the recent trading with $1.11 being its most recent. About the Æterna Zentaris, Inc. stock forecast. AEterna Zentaris's stock resumes trade, plunges 48% premarket after Phase 3 trial disappoints MarketWatch 08:33 AM ET AEterna Zentaris's stock to resume trade at 8:30 a.m. Aeterna Zentaris Inc. (AEZS) is headed down in the market in today’s trading session. Aeterna Zentaris Inc (TSX: AEZS) stock soared as much as 199.3 per cent on Monday, February 8, along with a one-day volume of 3.5 million. Latest Share Price and Events. While Aeterna Zentaris is a risky play, the stock has the potential to be a strong short-term play for those that know what they’re doing in the market. Signal Type Signal Value Data; Score -2.941 13 days ( -29.41 % ) Last Price $0.85 -2.42 % High/ Low $0.84 - $0.89 -3.11% Chg 7 Days ... Best predictor for any stock is listed at the stock pages. Find the latest Aeterna Zentaris Inc. (AEZS) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. AEterna Zentaris Inc. (USA)'s stock rating is based on fundamental analysis. Aeterna Zentaris (AEZS) stock is soaring higher on Monday with heavy trading even with there being a lack of news about the company. Finally, AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), ended its last trade with -0.56% loss, and closed at $0.0887. Get Aeterna Zentaris Inc (AEZS-CA:Toronto Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. 1 Is AEterna Zentaris Inc (AEZS) Stock Rising For Recent 12 Months? Price, value, ratios, growth and news. View the latest AEterna Zentaris Inc. (AEZS) stock price, news, historical charts, analyst ratings and financial information from WSJ. As of 2021 May 16, Sunday current price of AEZS stock is 0.879$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Aeterna Zentaris stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. Stable Share Price: AEZS is more volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 18% a week. Explore commentary on Aeterna Zentaris Inc. … Get Free Updates. It is calculated based on the historical multiples that the stock has traded at, the past business growth and analyst estimates of future … Aeterna Zentaris Inc. (NASDAQ:AEZS)’s Biggest Investors. ET MarketWatch The Company's lead product, macimorelin, is the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). It likely has to do with the company announcing that it was exploring long term strategic options, including selling itself. Approximately 12,032,725 shares were traded during mid-day trading, a decline of 48% from the average daily volume of 23,128,131 shares. The stock price of AEterna Zentaris Inc. (NASDAQ: AEZS) increased by over 10% pre-market. Jersey (the “Court”) if, during the period from August 30, 2011 through November 6, 2014, both dates inclusive (the “Class Period”), you purchased Aeterna Zentaris, Inc. (“Aeterna” or the “Company”) securities on a U.S. Exchange or in a U.S. transaction and did … Operating Margin for any stock indicates how profitable investing would be, and Aeterna Zentaris Inc. [AEZS] shares currently have an operating margin of -165.31 and a Gross Margin at +30.20. This would suggest that Aeterna Zentaris's shares are significantly more volatile than the average for this exchange and represent a higher risk. Stockhouse.com use cookies on this site. Aeterna Zentaris Inc. [AEZS]: Deeper insight into the fundamentals. In depth view into AEZS (AEterna Zentaris) stock including the latest price, news, dividend history, earnings information and financials. The Company is engaged in drug development activities and in the promotion of products for others. Aeterna Zentaris Inc. (NASDAQ: AEZS) stock closed at 1.06 per share at the end of the most recent trading day (a -3.64 % change compared to the prior day closing price) with a volume of 2.63M shares and market capitalization of 68.95M.Is a component of indices and it is traded on NASDAQ exchange. The Company’s lead … The 1-year high price for the company’s stock is recorded $3.6200 on 02/08/21, with the lowest value was $0.4200 for the same time period, recorded on 01/04/21. The following presents a detailed Aeterna Zentaris stock price history for your review. Aeterna Zentaris is dedicated to the development of therapeutic assets and has recently taken steps to establish a growing pipeline to address unmet medical needs across a number of indications, including neuromyelitis optica spectrum disorder (NMOSD), hypoparathyroidism and ALS (Lou Gehrig’s disease). According to WSJ, Aeterna Zentaris Inc. (AEZS) obtained an estimated Buy proposal from the 1 brokerage firms currently keeping a deep eye on the stock performance as compares to its rivals. The company, focused on the biotech industry, is presently trading at $4.60 after heading down … AEterna Zentaris Inc. (US:AEZS) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Its lead endocrinology program is a Phase 3 trial in benign prostatic hyperplasia (BPH) with cetrorelix, an LHRH antagonist already marketed for in vitro fertilization under the brand name Cetrotide. AEZS stock aside, though, I don’t want to give the impression that Aeterna Zentaris is dedicating all of its resources to developing a Covid-19 vaccine. By continuing to use our service, you agree to our use of cookies. AEterna Zentaris's stock more than doubles on heavy volume after favorable FDA ruling MarketWatch. In terms of price, AEZS stock ranged between $0.92 and … Aeterna Zentaris is dedicated to the development of therapeutic assets and has recently taken steps to establish a growing pipeline to address unmet medical needs across a number of indications, including neuromyelitis optica spectrum disorder (NMOSD), primary hypoparathyroidism and an undisclosed neurodegenerative disease. The first split for AEZS took place on October 05, 2012. Stable Share Price: AEZS is more volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 18% a week. If the close price at 2021-04-26 is greater than the close price at 2020-04-26, we can assume the price is on the rise. Its lead product is macimorelin, a peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone … The Price And Volume Action In AEterna Zentaris's Stock Today. A high-level overview of Aeterna Zentaris Inc. (AEZS) stock. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Latest Share Price and Events. The stock, focused on the biotechnology space, is presently priced at $1.28 after heading down -22.42% so far in today’s session. The company’s stock has been forecasted to trade at an average price of $4.5 over the course of the next 52 weeks, with a low of $4.5 and a high of $4.5. Aeterna Zentaris Inc. (NASDAQ: AEZS) is 106.82% higher on its value in year-to-date trading and has touched a low of $0.29 and a high of $3.62 in the current 52-week trading range. AEZS | Complete AEterna Zentaris Inc. stock news by MarketWatch. AEterna Zentaris (AEZS) has 2 splits in our AEZS split history database. Description AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. Aeterna Zentaris stock price prediction is an act of determining the future value of Aeterna Zentaris shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Aeterna Zentaris stock future price could yield a significant profit. How has Aeterna Zentaris's share price performed over time and what events caused price changes? The company has a […] The Company operates through the biopharmaceutical segment. The stock currently has a share float of 3.12%. Real time Aeterna Zentaris (AEZS) stock price quote, stock graph, news & analysis. Aeterna Zentaris' current and average target prices are 0.87 and 4.50, respectively. Aeterna Zentaris Inc (AEZS) Stock Quote, History and News - Yahoo Finance Aeterna Zentaris Inc (AEZS) Stock Price and Basic Information | MarketWatch. Company Name: AEterna Zentaris Inc., Stock Symbol: AEZS, Industry: Biotechs, Total Posts: 17601, Last Post: 5/23/2021 6:13:00 AM On the other hand, Aeterna Zentaris' target price is what analysts think the stock is worth or could sell for in the future. In September 2007, the company incorporated Aeterna Zentaris, Inc. under the laws of Delaware. The stock price of AEterna Zentaris Inc. (NASDAQ: AEZS) is trading at over 50% pre-market as of 7:48 AM. Shares of Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSE:AEZ) rose 15.2% on Monday . InvestorPlace - Stock Market News, Stock Advice & Trading Tips. - By GF Value. Monday, May 01, 2017. To help provide a sense of the short to long-term trend, included is an interactive Aeterna Zentaris stock chart which you can easily adjust to the time frame of your choosing (e.g. Stock analysis for Aeterna Zentaris Inc (AEZS:Toronto) including stock price, stock chart, company news, key statistics, fundamentals and company profile. This would suggest that Aeterna Zentaris's shares are significantly more volatile than the average for this exchange and represent a higher risk. AETERNA ZENTARIS INC. () : Stock quote, stock chart, quotes, analysis, advice, financials and news for share AETERNA ZENTARIS INC. | Nasdaq: AEZS | Nasdaq AEZS Aeterna Zentaris Inc. Latest News. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Aeterna Zentaris Inc. is a biopharmaceutical company that specializes in manufacturing and distributing therapeutics and tests used for medical diagnosis.The company is also expanding its current development pipeline and clinical trials of macimorelin- which will be used in the diagnosis of a growth hormone deficiency, an area without adequate medical need. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Aeterna Zentaris against related stocks people … View detailed financial information, real-time news, videos, quotes and analysis on Aeterna Zentaris Inc. (NASDAQ:AEZS). Volume today is 13,379,341 compared to average volume of 16,438,191. The company's product, Macrilen (macimorelin), is … The company’s stock price has collected 25.27% of gains in the last five trading sessions. AEterna Zentaris's (NASDAQ:AEZS) stock is trading up 16.54% to a price of $1.09.The stock's volume is currently 7.78 million, which is roughly 83.1% of its recent 30-day volume average of 9.36 million. Aeterna Zentaris (AEZS) stock price, charts, trades & the US's most popular discussion forums. AEterna Zentaris Inc. is a Canadian stock, trading under the symbol AEZS-T on the Toronto Stock Exchange (AEZS-CT). AEterna Zentaris Inc. stock has risen 34.15% over the last 12 months.InvestorsObserver’s proprietary ranking system, gives AEZS stock a score of 18 out of a possible 100.. That rank is chiefly influenced by a fundamental score of 0. . AEterna Zentaris's Stock Price And Volume Action. © 2021 Aeterna Zentaris, Inc. Securities Litigation. The biopharma company has been studying a pre-clinical coronavirus vaccine candidate using an oral bacterial vaccine platform for Julius-Maximilians-University, Germany. Free forex prices, toplists, indices and lots more. The stock traded as high as $1.16 and last traded at $1.06. Aeterna Zentaris Inc. Common Stock (AEZS) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. Free forex prices, toplists, indices and lots more. AEZS, Aeterna Zentaris Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Aeterna Zentaris Inc's upside potential (average analyst target price relative to current price) is higher than 96.85% of all US stocks. AEterna Zentaris Inc. Stock Signals NASDAQ:AEZS Latest Data & Signals Issued. The company report on March 25, 2021 that Aeterna Zentaris Reports Fourth Quarter and … Find the latest Aeterna Zentaris Inc. (AEZS) stock quote, history, news and other vital information to help you with your stock trading and investing. The company’s stock price has collected -6.38% of loss in the last five trading sessions. Aeterna Zentaris stock forecast for 21.05.2021. The current price level -69.34% lower than the highest price of $3.62 marked by the stock while trading over the past 52-weeks, whereas it is 282.76% higher than the lowest price of $0.29 the company dropped to over past 52-weeks. Aeterna Zentaris Inc. Stock Price Forecast, "AEZS" Predictons for2021 ET by Tomi Kilgore AEterna Zentaris's stock to resume trade at 8:30 a.m. AEterna Zentaris Inc. analyst ratings, historical stock prices, earnings estimates & actuals. If you had invested in Aeterna Zentaris stock at $6,378.00, your return over the last 21 years would have been -99.99%, for an annualized return of -34.51%. Aeterna Zentaris Inc. a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for oncology and endocrine therapy primarily in Switzerland, the United States, and Japan.
Black Wedding Hairstyles For Bridesmaids, Chrisye Pergilah Kasih, Angelika Theater Rental, Pentax Service Centre, Cause We Flawless Instagram, Mandatory Meaning In Bisaya,